PAREXEL International    (<< View Graph >>)
PAREXEL International is a global contract
research organization providing clinical trials outsourcing services to major pharmaceutical companies worldwide. We worked with PAREXEL’s founders to grow the company from a niche market consulting firm into a multinational pharmaceutical services company generating more than $1 billion in annual revenue. Following our initial investment in 1986, we worked with PAREXEL’s management team to define and implement a strategy to consolidate the highly fragmented contract research industry and take advantage of its extraordinary growth potential. We developed primary market research for PAREXEL on the contract research organization industry and created a database of acquisition candidates, from which the company completed several acquisitions. PAREXEL is now the third largest contract research organization in the world, with over 7,000 employees. PAREXEL completed its initial public offering in November 1995. The distributed value of our $2.8 million investment in PAREXEL was $38.6 million.